¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cellular infiltration"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular infiltration
    ¼¼Æ÷ħÀ±
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogenic infiltration
    ´ç¿øÄ§À±
  • infiltration
    ħÀ±, ħ½À
  • infiltration analgesia
    ħÀ±ÁøÅë
  • infiltration anesthesia
    ħÀ±¸¶Ãë
  • lipid infiltration
    ÁöÁúħÀ±
  • local infiltration
    ±¹¼ÒħÀ±
  • marrow infiltration
    °ñ¼öħÀ±
  • primary infiltration
    ÃʱâħÀ±
  • purulent infiltration
    °í¸§Ä§À±, È­³óħÀ±
  • cellular
    ¼¼Æ÷-
  • cellular adhesiveness
    ¼¼Æ÷ºÎÂø¼º
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • cellular antibody
    ¼¼Æ÷Ç×ü
  • cellular cast
    ¼¼Æ÷¿øÁÖ
  • cellular cementum
    ¼¼Æ÷½Ã¸àÆ®Áú
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular type
    ¼¼Æ÷Çü
  • infiltration anesthesia
    ħÀ±¸¶Ãë
  • infiltration
    ħÀ±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular infiltration
    ¼¼Æ÷ħÀ±
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • infiltration analgesia
    ħÀ±ÁøÅë
  • infiltration anesthesia
    ħÀ±¸¶Ãë
  • glycogenic infiltration
    ±Û¸®ÄÚ°ÕħÀ±
  • infiltration
    ħÀ±
  • lipid infiltration
    ÁöÁúħÀ±
  • local infiltration
    ±¹¼ÒħÀ±
  • marrow infiltration
    °ñ¼öħÀ±
  • primary infiltration
    ÃʱâħÀ±
  • purulent infiltration
    °í¸§Ä§À±, È­³óħÀ±
  • cellular adhesiveness
    ¼¼Æ÷ºÎÂø¼º
  • cellular aging
    ¼¼Æ÷³ëÈ­
  • cellular antibody
    ¼¼Æ÷Ç×ü
  • cellular
    ¼¼Æ÷-
  • cellular cartilage
    ¼¼Æ÷¿¬°ñ
  • cellular cast
    ¼¼Æ÷¿ø±âµÕ, ¼¼Æ÷¿øÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • hypersensitivity, cellular
    ¼¼Æ÷¼º °ú¹Î¹ÝÀÀ
  • impaired cellular immunity
    ¼¼Æ÷¼º ¸é¿ªºÎÀü(á¬øààõØóæ¹ÝÕîï).
  • PIE syndrome => pulmonary infiltration with eosinophilia syndrome
    È£»ê±¸Áõ°¡¼º ÆóħÀ± ÁõÈıº
  • glycogenic infiltration
    ±Û¸®ÄÚ°ÕħÀ±.
  • primary infiltration
    ÃʱâħÀ±
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ).
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ)
  • purulent infiltration
    È­³ó¼º ħÀ±(ûùÒÛàõ öÙëÈ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cellular infiltration
    ¼¼Æ÷ħÀ±(¡­öÙëÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glycogenic infiltration
    ±Û¸®ÄÚ°ÕħÀ±.
  • infiltration analgesia
    ħÀ±¼º ¹«Åë°¢(Áõ)(¡­àõÙí÷ÔÊÆñø).
  • infiltration anesthesia
    ħÀ±¸¶Ãë(¹ý)(¡­Ø«ö­ Ûö).
  • infiltration of neutrophils
    Áß¼º±¸Ä§À±
  • lipid infiltration
    ÁöÁúħÀ±(¡­öÕëÈ).
  • local infiltration
    ±¹¼ÒħÀ±(¹ý).
  • lymphocytic infiltration
    ¸²ÇÁ±¸ ħÀ±
  • marrow infiltration
    °ñ¼öħÀ±
  • paraneural infiltration
    ½Å°æÁÖÀ§Ä§À±¸¶Ãë(ãêÌèñ²êÌöÕëÈØ«ö­).
  • perihilar infiltration
    Æó¹®ÁÖÀ§ ħÀ±
  • periurethral infiltration
    ¿äµµÁÖÀ§Ä§À±.
  • primary infiltration
    ÃʱâħÀ±
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ).
  • pulmonary infiltration
    ÆóħÀ±(øËöÙëÈ)
  • purulent infiltration
    È­³ó¼º ħÀ±(ûùÒÛàõ öÙëÈ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á